1369 CIS-demasking cytokine linker technology allows selective cytokine delivery to activated immune cells while sparing others and peripheral toxicity
Main Authors: | , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |